Pelthos Therapeutics, Inc. (PTHS)
23.19
+0.16
(+0.69%)
USD |
NYAM |
Jan 22, 12:44
Pelthos Therapeutics Market Cap: 15.30M for Jan. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ligand Pharmaceuticals, Inc. | 4.055B |
| Agenus, Inc. | 114.95M |
| Travere Therapeutics, Inc. | 2.644B |
| Inhibrx Biosciences, Inc. | 1.150B |
| Palvella Therapeutics, Inc. | 1.111B |
Market Cap Related Metrics
| PS Ratio | 7.912 |
| PEG Ratio | -0.0022 |
| Price to Book Value | 0.2626 |
| Price | 23.19 |
| Earnings Yield | -61.20% |
| PEGY Ratio | -0.0022 |